Wenbo Ma
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 6
- Physiology top 5%
- Sensory Systems top 5%
- Immunology top 10%
-
- Cancer Research and Treatments 8
-
- Nonlinear Optical Materials Studies 8
-
- Cancer-related gene regulation 7
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 6
-
- Hippo pathway signaling and YAP/TAZ 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Cited by
- Cancer ResearchOncologyPhysiology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wenbo Ma
71 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 298
- Oncology 404
- Physiology 59
- Sensory Systems 62
- Immunology 260
Countries citing papers authored by Wenbo Ma
This map shows the geographic impact of Wenbo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbo Ma more than expected).
Fields of papers citing papers by Wenbo Ma
This network shows the impact of papers produced by Wenbo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbo Ma. The network helps show where Wenbo Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenbo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 3 | |
| 13 | Circular RNA cancer vaccines drive immunity in hard-to-treat malignanciesbreakdown → | 2022 | 153 |
| 14 | 2021 | 8 | |
| 15 | 2020 | 0 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 20 | |
| 19 | 2017 | 122 | |
| 20 | 2010 | 105 |
About Wenbo Ma
Wenbo Ma is a scholar working on Horticulture, Biotechnology and Sensory Systems, having authored 82 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Research and Treatments (8 papers), Nonlinear Optical Materials Studies (8 papers), Cancer-related gene regulation (7 papers), RNA modifications and cancer (6 papers), Cancer Cells and Metastasis (6 papers), Epigenetics and DNA Methylation (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Cancer Research (298 citations), Oncology (404 citations) and Physiology (59 citations). Wenbo Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shuren Zhang, Yanhong Wu, Tong Wu, Weina Chen, Chang Han, Kyoungsub Song, Chunxia Zhou, Hyunjoo Kwon, Jinqiang Zhang and Guocan Yu. Their work appears in journals such as Advanced Materials, PLoS ONE and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.